| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |